M a et al. reported impressive syntheses of the bis-guanidine alkaloids sceptrin and massadine (1) . Examination of the absolute configurations of the synthetic and natural materials revealed that sceptrin and massadine, versus ageliferin, have mismatched chirality. The authors conclude that they "uncover enantiodivergence as a new biosynthetic paradigm for natural products" and "Although enantiomeric biosynthesis that produces both enantiomers of a natural product has been reported [(2)], enantiodivergent biosynthesis that produces opposite enantiomers of natural products as congeners described herein is unknown." Unfortunately, these statements overlook a substantial body of literature unambiguously demonstrating that this phenomena is well known. The authors' work is another affirmation that nature has evolved enantiodivergent biogeneses leading to new secondary metabolic diversity. The biogenesis postulated ( Fig. 1) accommodates the reassigned stereochemistry, providing a working hypothesis for experimental verification (1) . Although congeneric metabolites with opposite chirality have been confirmed through this work, the details of the biosynthetic pathways to these alkaloids remain unknown.
Numerous examples of enantiodivergent biosynthesis producing congeners of opposite absolute stereochemistry and distinct framework connectivity within the same producing organism are well known (2); a nonexhaustive list is shown in Fig. 2 (3-15) . Little is known about the intricate genetic, biocatalytic, and mechanistic details of how enantiomeric, or pseudoenantiomeric metabolites, are constructed. Co-isolated congeners in the same, as well as distinct, oxidation states-presumably derived from the same pathway or via parallel pathways-are evident, including the biogenesis postulated by Ma (1). Pseudo-enantiomeric congeners encompass disparate families of metabolites, including polyketides, terpenes, alkaloids, and amino acid derivatives. Pseudo-enantiomeric diastereomeric congeners (2, 10, 11), as well as instances of natural products sharing structural cores of opposite absolute stereochemistry, but differing in substitution patterns and oxidation states, are known (Fig. 2) . Lignans, derived by the homodimerization of cinnamic alcohol units in plants, are particularly relevant, with (+)-syringaresinol and (-)-lariciresinol from Dirca occidentalis and Wikstroemia elliptica being salient examples.
In a particularly interesting system, Shen and others (14) demonstrated that nonactin and congeners are biosynthesized in Streptomyces griseus by a pair of enantiospecific pathways, which construct (+)-and (-)-nonactic acid, as well as both enantiomers of the higher congeners homononactic acid and bishomononactic acid. The macrotetrolides are assembled from these apparently biochemically compartmentalized, enantiomeric fragments (Fig. 3) .
Plant terpenoids, such as copalyl pyrophosphate (CPP) derivatives, constitute various families of co-isolable pseudo-enantiomeric congeners, with ent-kaurene and 9,13-epoxy-labd-14-ene from Marrubium vulgare and the production of (-)-abietic acid and the ubiquitous plant hormone gibberellin A12 from spruce trees (Picea glauca and P. sitchensis) being illustrative. It is well known that higher plants produce both enantiomers of CPP, the core substrates from which numerous terpenoid congeners of opposite absolute stereochemistry arise (7-10). Indeed, many terpene cyclases have been documented to produce racemic or partially racemic metabolites (2), demonstrating a further mechanism whereby nature diversifies secondary metabolite stereochemistry. Selective catabolism or tailoring of one enantiomer of a biosynthetic racemate (i.e., by an enantiospecific oxidase or reductase) is another strategy for the coproduction of pseudoenantiomeric congeners and may also be one means by which partially racemic natural products, as well as pseudo-enantiomeric congeners, might arise.
Fungal prenylated indole alkaloids, such as brevianamides A and B, constitute another example of pseudo-enantiomeric diasteromeric congeners from the same biosynthetic pathway with structural cores of opposite absolute configuration (12) . Related examples are Penicillium sp. congeners (-)-VM55599 and paraherquamide A (13) and the co-isolated congeners (+)-versicolamide B and (-)-stephacidin A in Aspergillus versicolor (13) .
In several instances, enantiodivergent gene clusters that direct congener secondary metabolite biosynthesis appear in disparate organisms of distinct genus types and are not restricted to speciation. Evolutionary selection pressure must be the obligatory driving force for the diversification of secondary metabolite structure and stereochemistry, with enantiodivergence being among the palette of nature's tools. As more natural products are identified from the vast reservoir of as-yet-undiscovered organisms on earth, it is tantalizing to ponder the adaptive importance of the evolution, conservation of genes, and apparent distribution of genes between organisms that diversify secondary metabolites structurally and stereochemically. Although little is understood regarding genetic and biochemical mechanisms that control enantioselectivity in pathways generating enantiodivergent congeners, preliminary information is emerging (7) (8) (9) (14) (15) (16) . For example, genome sequencing, gene cluster mining, and annotation of enzymes specifying the biosynthesis of (-)-stephacidin A and (+)-versicolamide B reveal high amino acid sequence identity (79 to 88%) between every structural pathway protein (16) . Here, enantiodivergence is clearly a result of orthologous divergent, rather than paralogous convergent evolutionary processes. That nature clearly interrogates stereochemical diversity in the context of structural diversity is firmly established, and many more examples are anticipated. The interesting pyrrole-imidazole alkaloids (1) provide a provocative working hypothesis from which to investigate the putative existence of yet another striking example of enantiodivergent congener biosynthesis. The claim to having discovered enantiodivergent congener biosynthesis must be tempered in the context of a substantial body of published evidence dating back four decades.
